CIPLA LTD.
Smart Quotes
Trade Value (Rs. in Lacs) | 0.03 |
Dividend Yield(%) | 0.51 |
TTM EPS (Rs.) | 32.98 |
P/E Ratio | 23.85 |
Book Value (Rs.) | 233.61 |
Face Value (Rs.) | 2 |
MCap (Rs. in Mn) | 634321.46 |
Price/Earning (TTM) | 19.58 |
Price/Sales (TTM) | 4.71 |
Price/Book (MRQ) | 3.37 |
PAT Margin (%) | 17.10 |
ROCE (%) | 18.08 |
Management Info :
Y K Hamied - Chairman Umang Vohra - Managing DirectorRegistered Office :
Address :
Cipla House,Peninsula Business Park,Ganpatrao Kadam Marg, Lower Parel,
Mumbai,
Maharashtra-400013
Phone : 022-24826000 / 022-24826951
Email : cosecretary@cipla.com
Website : www.cipla.com
QTR Dec 20 | ANNUAL 20 | |
---|---|---|
Net Profit | 6989.3 | 23181.7 |
Gross Profit | 9473.7 | 29643.1 |
Operating Profit | 10922.7 | 36001.4 |
Net Sales | 37315.5 | 126591.5 |
Sanofi India (BSE)![]() | M.Cap ( in Cr) 19043.68 |
Abbott India (BSE)![]() | M.Cap ( in Cr) 30591.88 |
Orchid Pharma (BSE)![]() | M.Cap ( in Cr) 3612.86 |
Alembic Pharma (BSE)![]() | M.Cap ( in Cr) 18067.10 |
Natural Capsules (BSE)![]() | M.Cap ( in Cr) 73.17 |
|
PROMOTERS | 36.7 % |
|
NON-INSTITUTION | 23.25 % |
|
FI/BANKS/INSURANCE | 2.08 % |
|
MUTUAL FUNDS/UTI | 15.58 % |
|
FII | 0.01 % |
|
GOVERNMENT | 0 % |
Scheme Name | Hold(%) |
---|---|
ICICI Pru Pharma Health... | 10.03 |
Nippon India Pharma Fun... | 9.35 |
DSP Healthcare Fund-Reg... | 9.28 |
Aditya Birla SL Pharma ... | 9.24 |
Tata India Pharma & Hea... | 8.99 |
SBI Healthcare Opp Fund... | 8.95 |